Published findings include: Clean endocrine profile (no significant ACTH/cortisol/prolactin spike) GH peak at approximately 40 minutes post-injection Return to baseline within 3 hours No significant hunger stimulation (unlike GHRP-6)
Class Ia: Quinidine, Procainamide, Disopyramide Indications: Supraventricular tachyarrhythmias, recurrent atrial fibrillation, ventricular tachycardia (VT), ventricular fibrillation (VF), Brugada syndrome, short QT syndrome (SQTS) (15)(16)(18)
Cagrilintide mimics amylin, a hormone co-secreted with insulin from pancreatic beta cells, reducing food intake and delaying gastric emptying through a complementary but mechanistically distinct pathway
When will I notice improvements
Medication alone isn't the answer
Realistic Goal-Setting Semaglutide is effective, but its not an instant fix